Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles Congreve

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|October 3, 2019
Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 ReceptorsRie Suzuki, Giles A Brown, John A Christopher, et al.
Methods in Enzymology|March 5, 2011
Fragment screening of stabilized G-protein-coupled receptors using biophysical methodsMiles Congreve, Rebecca L Rich, David G Myszka, et al.
Molecular Pharmacology|September 20, 2015
Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic ReceptorTomomi Sato, Jillian Baker, Tony Warne, et al.
Progress in Medicinal Chemistry|October 23, 2025
The rise of AlphaFold in drug designAdrian Stecula, Rebecca Paul, Kevin Litchfield, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to beta-secretaseChristopher W Murray, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|June 14, 2011
Biophysical mapping of the adenosine A2A receptorAndrei Zhukov, Stephen P Andrews, James C Errey, et al.
Journal of Chemical Information and Modeling|June 17, 2020
Accurate Prediction of GPCR Ligand Binding Affinity with Free Energy PerturbationFrancesca Deflorian, Laura Perez-Benito, Eelke B Lenselink, et al.
Journal of Medicinal Chemistry|January 1, 2008
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activatorMartyn Frederickson, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|February 17, 2006
Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitorsNigel Howard, Chris Abell, Wendy Blakemore, et al.
Journal of Medicinal Chemistry|January 19, 2012
Identification of novel adenosine A(2A) receptor antagonists by virtual screeningChristopher J Langmead, Stephen P Andrews, Miles Congreve, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|October 3, 2019
Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 ReceptorsRie Suzuki, Giles A Brown, John A Christopher, et al.
Methods in Enzymology|March 5, 2011
Fragment screening of stabilized G-protein-coupled receptors using biophysical methodsMiles Congreve, Rebecca L Rich, David G Myszka, et al.
Molecular Pharmacology|September 20, 2015
Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic ReceptorTomomi Sato, Jillian Baker, Tony Warne, et al.
Progress in Medicinal Chemistry|October 23, 2025
The rise of AlphaFold in drug designAdrian Stecula, Rebecca Paul, Kevin Litchfield, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to beta-secretaseChristopher W Murray, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|June 14, 2011
Biophysical mapping of the adenosine A2A receptorAndrei Zhukov, Stephen P Andrews, James C Errey, et al.
Journal of Chemical Information and Modeling|June 17, 2020
Accurate Prediction of GPCR Ligand Binding Affinity with Free Energy PerturbationFrancesca Deflorian, Laura Perez-Benito, Eelke B Lenselink, et al.
Journal of Medicinal Chemistry|January 1, 2008
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activatorMartyn Frederickson, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|February 17, 2006
Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitorsNigel Howard, Chris Abell, Wendy Blakemore, et al.
Journal of Medicinal Chemistry|January 19, 2012
Identification of novel adenosine A(2A) receptor antagonists by virtual screeningChristopher J Langmead, Stephen P Andrews, Miles Congreve, et al.
Pageof 6